Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Serbia,Argentina,France,Croatia,Finland,Mexico,Czech Republic,Romania,Poland,Bulgaria
nct
Update Il y a 5 ans
A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
The purpose of the study is to assess whether treatment with SR58611A can prevent relapse of depressive symptoms in patients with major depressive disorder. Relapse will be assessed using the MADRS scale.Patients who demonstrate improvement in depressive symptoms at the end of the initial 12-week open-label treatment period with SR58611A are randomized to continue SR58611A or switch to placebo under double blind conditions for up to 52 weeks of additional treatment. The secondary objective is to evaluate the safety of SR58611A in patients with MDD.
Country
Argentina
,
Bulgaria
,
Croatia
,
Czech Republic
,
Finland
,
France
,
Mexico
,
Poland
,
Romania
,
Russian Federation
,
Serbia
,
Slovakia
,
South Africa
,
organs
None
Specialty
None
Closed trial
More information
1